Paolo Tarantino: Antibody drug conjugates (ADCs) are leading to relevant survival improvements for multiple types of cancer.
Paolo Tarantino, MD and researcher at the European Institute of Oncology and clinical research fellow at the Dana-Farber Cancer Institute, shared the following insights on Twitter:
“Antibody drug conjugates (ADCs) are leading to relevant survival improvements for multiple types of cancer. Yet, they have only partly fulfilled the promise of the “magic bullet”, given that they’re commonly burdened with chemotherapy-related side effects (e.g. nausea, neutropenia, alopecia) as well as some less understood toxicities.
Thanks to Medscape for this interview on ADCs toxicities and for highlighting our recent article published on Nature Reviews (for details click here).
Looking forward to discussing more about this important topic with Patricia LoRusso, Elisabeth De Vries, Raffaele Colombo, Anthony Tolcher at the upcoming AACR-NCI-EORTC “Triple Meeting” (Plenary Session II). (For details click here).
For details click here.
Source: Paolo Tarantino/LinkedIn
-
16:39 03/12Rami Manochakian: A special supplement highlighting major data from the IASLC 2023
-
16:28 03/12Jamie Ostroff: A call to action to improve the widespread adoption of smoking cessation guidelines in cancer care
-
16:18 03/12Karen Merritt: The tragic story of Dr. Anil Kapoor who died after one dose of 5FU, just like my mother
-
16:14 03/12Mark Storey: From asymptomatic to oligo, we remain a critical component of treatment
-
15:51 03/12Ishwaria Subbiah: Interesting new study published in the JCO CCI evaluates the utility and privacy of synthetic breast cancer clinical trial data sets
-
16:34 03/12Tedros Adhanom Ghebreyesus: Grateful to Namibia’s Prime Minister Saara Kuugongelwa-Amadhila for her commitment to health
-
18:08 02/12100 Influential Celebrities in Oncology: The 2023 Edition – Part 5
-
16:50 02/12Mara Antonoff: When your famous friends come back to visit their humble beginnings
-
16:12 02/12Nirmala Bhoo Pathy: To all the working mothers out there
-
07:43 02/12Nagashree Seetharamu: What’s in your he(ART)?
-
16:43 02/12In our recent survey, nearly 1,700 ASCO members shared feedback on the ABIM MOC requirements - ASCO
-
17:34 28/11The International Association of Cancer Registries annual conference - IARC
-
18:05 26/11Submit your abstract by 13 February for ESMO-Breast-24 - ESMO
-
17:58 26/11Lisa A. Lacasse: My sincere gratitude to the ACS CAN team, our incredible volunteers, and supporters for another outstanding year
-
16:47 16/11How social determinants can influence a patient’s ability to stay in treatment - ASCO
-
17:33 02/12Leukaemia and Myeloma Research UK awarded grants to Neil Rodrigues and Concetta Bubici
-
19:18 01/12Maria Kavallaris has been awarded the prestigious Royal Society of NSW Walter Burfitt Prize for 2023 - Children's Cancer Institute
-
18:35 01/12Sara Beltrán Ponce: Honored to be awarded the Eleanor Montague Distinguished Resident Award in Radiation Oncology
-
17:25 29/11NIH Director’s Early Independence Award supports junior scientists to launch independent careers - National Cancer Institute
-
17:07 29/11Santhosh Kumar Devadas: I’m starting a new position as a Professor of Medical Oncology and Chief of Bone Marrow Transplant at Ramaiah Memorial Hospital and Ramaiah Medical College